Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064552
Filing Date
2025-05-06
Accepted
2025-05-06 16:40:22
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bioa-20250331.htm   iXBRL 10-Q 2480758
2 EX-31.1 bioa-ex31_1.htm EX-31.1 16291
3 EX-31.2 bioa-ex31_2.htm EX-31.2 16105
4 EX-32.1 bioa-ex32_1.htm EX-32.1 8728
5 EX-32.2 bioa-ex32_2.htm EX-32.2 8811
6 GRAPHIC img42194710_0.jpg GRAPHIC 1040511
  Complete submission text file 0000950170-25-064552.txt   12085481

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bioa-20250331.xsd EX-101.SCH 1291532
73 EXTRACTED XBRL INSTANCE DOCUMENT bioa-20250331_htm.xml XML 1676539
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42279 | Film No.: 25917920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)